|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.48 USD | +1.39% |
|
-1.24% | +18.75% |
| Apr. 17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
| Apr. 09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
On a per-share basis, the
The drugmaker posted revenue of
ANI shares have declined 54% since the beginning of the year. The stock has declined 65% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a
Copyright by Automated Insights, Inc. All rights reserved., source
| 1st Jan change | Capi. | |
|---|---|---|
| +18.75% | 1.35B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
ANI PHARMACEUTICALS, INC. 
